Description
Product Description: Supertest 450 Ice Pharmaceuticals
Supertest 450 by Ice Pharmaceuticals is a powerful and highly effective anabolic steroid blend designed to enhance muscle growth, strength, and overall performance. This premium product is a favorite among bodybuilders and athletes seeking rapid and impressive results.
Specific Details and Features:
- Blend of five high-quality testosterone esters
- Each ml contains 450mg of active ingredients
- Manufactured by Ice Pharmaceuticals, a reputable and trusted brand
- Pharmaceutical-grade quality assurance
- Available in a convenient 10ml vial
Benefits:
- Promotes significant muscle mass gains
- Enhances strength and power
- Improves nitrogen retention for increased protein synthesis
- Boosts red blood cell production for improved endurance
- Accelerates post-workout recovery
- Enhances libido and sexual performance
Possible Side Effects:
While Supertest 450 is a highly effective product, it is important to be aware of potential side effects. These may include:
- Estrogenic side effects such as water retention and gynecomastia
- Androgenic side effects such as acne, oily skin, and hair loss
- Suppression of natural testosterone production
- Potential cardiovascular strain
Usage and Dosage:
For beginners, a typical dosage of Supertest 450 is 300-500mg per week, administered via intramuscular injection. Experienced bodybuilders may opt for higher dosages, up to 800mg per week, depending on their goals and tolerance.
Value to the Buyer:
By choosing Supertest 450 from our online sports pharmacy Steroidspills in the UK, you can expect:
- Authentic and genuine Ice Pharmaceuticals product
- Competitive pricing
- Discreet packaging and secure delivery
- Excellent customer service and support
- Access to a wide range of other high-quality steroids and supplements
Invest in Supertest 450 today and experience the remarkable benefits it offers for your bodybuilding journey. Trust Steroidspills for all your performance-enhancing needs.
Reviews
There are no reviews yet.